What does Abattis Bioceuticals Corp. do?

Abattis Bioceuticals Corp. (ATTBF) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is ATTBF's market cap?

Abattis Bioceuticals Corp. (ATTBF) has a market capitalization of approximately $14,334, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does ATTBF pay a dividend?

No — Abattis Bioceuticals Corp. (ATTBF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Abattis Bioceuticals Corp. (ATTBF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

ATTBF

Abattis Bioceuticals Corp.

OTC·Medical, Pharmaceuticals · Healthcare

$0.00$0.00+0.00%

Market cap$14.33K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.74%CAGR −69.60%

Select date range

FromTo

Sep 19, 2012Aug 27, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

ATTBF does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 7

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueC$356.88K

Net Income−C$3.04M

Net Margin−852.4%

Operating Cash FlowC$9.41M

Capital ExpendituresC$5.06M

Free Cash FlowC$4.35M

Return on Equity−27.5%

Return on Invested Capital−3.0%

Net CashC$832.69K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for ATTBF and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how ATTBF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ATTBF and 80,000+ other tickers.

About Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

CEO: Robert G. Goodall
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: OTC
Employees: 48
Website: www.abattis.com

Peers

Peers Tab

ISOLF

Isodiol International Inc.

Cap

$4.9K

OWCP

OWC Pharmaceutical Research Corp.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About ATTBF

What does Abattis Bioceuticals Corp. do?: Abattis Bioceuticals Corp. (ATTBF) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is ATTBF's market cap?: Abattis Bioceuticals Corp. (ATTBF) has a market capitalization of approximately $14,334, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does ATTBF pay a dividend?: No — Abattis Bioceuticals Corp. (ATTBF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is ATTBF profitable?: Abattis Bioceuticals Corp. (ATTBF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.